UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON - TESTING OF STANDARD DRUGS FOR MYCOBACTERIUM TUBERCULOSIS (MTB) IN ANIMAL MODELS FOR MTB

PIID: 75N93021F00003Solicitation ID: 75N93021F00003

Signed Date: Aug 11, 2021Effective Date: Aug 15, 2021End Date: Closed on Jun 14, 2022

Award $

$348K

Vendor

UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON

NAICS

541715

Signed Date

Aug 11, 2021

Key Details

Dollars Obligated

$347,683.71

Base & All Options

$347,683.71

Awarding Agency

Awarding Sub-Agency

National Institutes of Health

NAICS Code

Parent IDIQ (PIID)

75N93021D00011

Product Service Code

AN11 - HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH

Extent Competed

FULL AND OPEN COMPETITION

Number of Offers

Place of Performance

GALVESTON, TX

TESTING OF STANDARD DRUGS FOR MYCOBACTERIUM TUBERCULOSIS (MTB) IN ANIMAL MODELS FOR MTB

On Aug 11, 2021, Department of Health and Human Services obligated $347,683.71 to UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON for testing of standard drugs for mycobacterium tuberculosis (mtb) in animal models for mtb. The award is classified under NAICS 541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY). Competition extent: full and open competition with 3 offers received. Performance is located in GALVESTON, TX. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541715 — related awards are listed below.